Lancet Oncol

ISSN	1474-5488
ISSN-L	-
IUID	ab4acc8f460b48d08cb38e4d100f62a0
Modified	2022-08-17T10:39:58.729Z
Created	2022-08-17T10:39:58.729Z

Year 2022

PubMed DOI Crossref

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial.

Tam CS, Brown JR, Kahl BS, ..., Robak T, Hillmen P

Lancet Oncol 23 (8) 1031-1043 [2022-08-00; online 2022-07-07]

Category: Drug Discovery Category: Health Type: Journal article

Add publication

Multiple copies

SciLifeLab Data Centre

Publications 9.2.2